Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease-Reference-Cited by-同舟云学术

Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease

Published:2019-09-02 Issue:1 Volume:10 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Krashia Paraskevi^ORCID,Cordella Alberto,Nobili Annalisa,La Barbera Livia,Federici Mauro^ORCID,Leuti Alessandro,Campanelli Federica,Natale Giuseppina,Marino Gioia,Calabrese Valeria^ORCID,Vedele Francescangelo,Ghiglieri Veronica,Picconi Barbara,Di Lazzaro Giulia,Schirinzi Tommaso,Sancesario Giulia,Casadei Nicolas,Riess Olaf,Bernardini Sergio,Pisani Antonio^ORCID,Calabresi Paolo,Viscomi Maria Teresa,Serhan Charles Nicholas^ORCID,Chiurchiù Valerio,D’Amelio Marcello,Mercuri Nicola Biagio^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-019-11928-w.pdf

Reference78 articles.

1. Schapira, A. H. V. & Tolosa, E. Molecular and clinical prodrome of Parkinson disease: implications for treatment. Nat. Rev. Neurol. 6, 309–317 (2010).

2. Lee, V. M.-Y. & Trojanowski, J. Q. Mechanisms of Parkinson’s disease linked to pathological alpha-synuclein: new targets for drug discovery. Neuron 52, 33–38 (2006).

3. Polymeropoulos, M. H. et al. Mutation in the alpha-synuclein gene identified in families with Parkinson’s disease. Science 276, 2045–2047 (1997).

4. Spillantini, M. G. et al. Alpha-synuclein in Lewy bodies. Nature 388, 839–840 (1997).

5. Singleton, A. B. et al. alpha-Synuclein locus triplication causes Parkinson’s disease. Science 302, 841 (2003).

Cited by 142 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolic routes for fatty acids;Omega-3 Fatty Acids;2025

2. Research progress in the mechanisms and functions of specialized pro-resolving mediators in neurological diseases;Prostaglandins & Other Lipid Mediators;2024-12

3. ⍺-Synuclein levels in Parkinson's disease – Cell types and forms that contribute to pathogenesis;Experimental Neurology;2024-09

4. The involvement of Slc7a11/xCT related iron accumulation on acupuncture intervention in 6-OHDA-induced Parkinson rat;Clinical Traditional Medicine and Pharmacology;2024-09

5. Neurodegenerative diseases and catechins: (−)-epigallocatechin-3-gallate is a modulator of chronic neuroinflammation and oxidative stress;Frontiers in Nutrition;2024-08-01